Abstract:Since March 2013, animal use for cosmetics testing for the European market has been banned. This requires a renewed view on risk assessment in this field. However, in other fields as well, traditional animal experimentation does not always satisfy requirements in safety testing, as the need for human-relevant information is ever increasing. A general strategy for animal-free test approaches was outlined by the US National Research Council`s vision document for Toxicity Testing in the 21st Century in 2007. It is now possible to provide a more defined roadmap on how to implement this vision for the four principal areas of systemic toxicity evaluation: repeat dose organ toxicity, carcinogenicity, reproductive toxicity and allergy induction (skin sensitization), as well as for the evaluation of toxicant metabolism (toxicokinetics) (Fig. 1). CAAT-Europe assembled experts from Europe, America and Asia to design a scientific roadmap for future risk assessment approaches and the outcome was then further discussed and refined in two consensus meetings with over 200 stakeholders. The key recommendations include: focusing on improving existing methods rather than favoring de novo design; combining hazard testing with toxicokinetics predictions; developing integrated test strategies; incorporating new high content endpoints to classical assays; evolving test validation procedures; promoting collaboration and data-sharing of different industrial sectors; integrating new disciplines, such as systems biology and high throughput screening; and involving regulators early on in the test development process. A focus on data quality, combined with increased attention to the scientific background of a test method, will be important drivers. Information from each test system should be mapped along adverse outcome pathways. Finally, quantitative information on all factors and key events will be fed into systems biology models that allow a probabilistic risk assessment with flexible adaptation to exposure scenarios and individual risk factors.

Alternative in vitro models used in the main safety tests of cosmetic products and new challenges

The Frontline of Alternatives to Animal Testing: Novel in Vitro Skin Model Application in Drug Development and Evaluation.

Application of In Vitro Methods in Preclinical Safety Assessment of Skin Care Products

A State-of-the-Art Review on the Alternatives to Animal Testing for the Safety Assessment of Cosmetics

The Ex Vivo Skin Model as an Alternative Tool for the Efficacy and Safety Evaluation of Topical Products

Pluripotent Stem Cells: an in Vitro Model for Nanotoxicity Assessments

Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies

In vitro 3D skin culture and its sustainability in toxicology: a narrative review

Towards skin-on-a-chip for screening the dermal absorption of cosmetics

Consensus report on the future of animal-free systemic toxicity testing

In Vitro Models for Anti-Aging Efficacy Assessment: A Critical Update in Dermocosmetic Research

Screening of repeated dose toxicity data in safety evaluation reports of cosmetic ingredients issued by the Scientific Committee on Consumer Safety between 2009 and 2019

A ready-to-use integrated in vitro skin corrosion and irritation testing strategy using EpiSkin™ model in China

Targeting the Complexity of In Vitro Skin Models: A Review of Cutting-Edge Developments

Skin corrosion test: a comparison between reconstructed human epidermis and full thickness skin models

Vaginal irritation testing—prospects of human organotypic vaginal tissue culture models

Research progress in the development of 3D skin models and their application to in vitro skin irritation testing

Development of 3D gingival in vitro models using primary gingival cells

Evaluation of the Safety of Cosmetic Ingredients and Their Skin Compatibility through In Silico and In Vivo Assessments of a Newly Developed Eye Serum

In vitro pharmacologic profiling aids systemic toxicity assessment of chemicals

Reliability and relevance of the ES®-RHE model for in vitro skin irritation test application